A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo

NCT07533019 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Vitiligo
Non-Segmental Vitiligo (NSV)

Interventions

DRUG: LY4005130
DRUG: Placebo

Sponsor

Eli Lilly and Company